• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

mRNA vaccine against SARS-CoV-2 response is comparable between patients on dialysis and healthy controls after adjustment for age, gender and history of COVID-19 infection.

作者信息

Rostoker Guy, Rouanet Stéphanie, Merzoug Myriam, Chakaroun Hiba, Griuncelli Mireille, Loridon Christelle, Boulahia Ghada, Gagnon Luc

机构信息

Department of Nephrology and Dialysis, Ramsay Santé, Hôpital Privé Claude Galien, Quincy-sous-Sénart, France.

Collège de Médecine des Hôpitaux de Paris, Paris, France.

出版信息

J Nephrol. 2025 Jan;38(1):301-304. doi: 10.1007/s40620-024-02161-w. Epub 2024 Dec 20.

DOI:10.1007/s40620-024-02161-w
PMID:39704990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11903638/
Abstract
摘要

相似文献

1
mRNA vaccine against SARS-CoV-2 response is comparable between patients on dialysis and healthy controls after adjustment for age, gender and history of COVID-19 infection.在对年龄、性别和新冠病毒感染史进行调整后，针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的信使核糖核酸（mRNA）疫苗反应在透析患者和健康对照者之间具有可比性。
J Nephrol. 2025 Jan;38(1):301-304. doi: 10.1007/s40620-024-02161-w. Epub 2024 Dec 20.
2
Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies.血液透析患者接种 BNT162b2 后序贯接种 mRNA-1273 ：血清转化和中和抗体的存在。
Nephrol Dial Transplant. 2022 May 25;37(6):1132-1139. doi: 10.1093/ndt/gfac018.
3
Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2.COVID-19 疫苗接种后血液透析患者的早期体液反应。
Clin J Am Soc Nephrol. 2021 Jul;16(7):1073-1082. doi: 10.2215/CJN.03700321. Epub 2021 May 24.
4
Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.肾移植受者和透析患者对 SARS-CoV-2 的体液免疫：SARS-CoV-2 感染和接种疫苗后解析的 IgA 和 IgG 模式。
Virol J. 2024 Jun 13;21(1):138. doi: 10.1186/s12985-024-02410-1.
5
Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected With SARS-CoV-2.对先前感染过严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的透析患者进行单剂量BNT162b2 mRNA疫苗接种后的体液免疫反应
Front Med (Lausanne). 2021 Aug 17;8:721286. doi: 10.3389/fmed.2021.721286. eCollection 2021.
6
Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.mRNA 或基于载体的 SARS-CoV-2 疫苗首剂在透析患者中的免疫原性：一项多中心前瞻性观察性初步研究。
J Nephrol. 2021 Aug;34(4):975-983. doi: 10.1007/s40620-021-01076-0. Epub 2021 May 29.
7
Factors predictive of anti-spike antibody titers after COVID-19 vaccination in hemodialysis patients.预测血液透析患者 COVID-19 疫苗接种后抗刺突抗体滴度的因素。
Adv Clin Exp Med. 2022 Aug;31(8):855-861. doi: 10.17219/acem/147360.
8
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
9
Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse.接种疫苗的透析患者中SARS-CoV-2抗体滴度的系列研究：未识别感染的患病率和血清反应持续时间
Kidney Med. 2023 Aug 25;5(11):100718. doi: 10.1016/j.xkme.2023.100718. eCollection 2023 Nov.
10
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.

引用本文的文献

1
Serological Correlate of Protection Established by Neutralizing Antibodies Differs Among Dialysis Patients with SARS-CoV-2 Variants of Concern.在感染新冠病毒变异株的透析患者中，由中和抗体建立的保护血清学关联存在差异。
Vaccines (Basel). 2025 May 13;13(5):518. doi: 10.3390/vaccines13050518.

本文引用的文献

1
Anti-SARS-CoV-2 Antibody Testing: Role and Indications.抗SARS-CoV-2抗体检测：作用与指征
J Clin Med. 2023 Dec 8;12(24):7575. doi: 10.3390/jcm12247575.
2
Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients.慢性肾脏病患者和肾移植受者对新冠病毒mRNA疫苗的病毒亚型特异性细胞免疫和体液免疫反应
Microorganisms. 2023 Jul 5;11(7):1756. doi: 10.3390/microorganisms11071756.
3
Covid-19 Vaccines - Immunity, Variants, Boosters.新冠疫苗——免疫、变种、加强针
N Engl J Med. 2022 Sep 15;387(11):1011-1020. doi: 10.1056/NEJMra2206573. Epub 2022 Aug 31.
4
Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study.接种疫苗后血液透析患者 COVID-19 严重程度的观察性队列研究。
Clin J Am Soc Nephrol. 2022 Jun;17(6):843-850. doi: 10.2215/CJN.16621221.
5
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.COVID-19 与透析：临床影响、免疫反应、预防和治疗。
Kidney Int. 2022 May;101(5):883-894. doi: 10.1016/j.kint.2022.01.022. Epub 2022 Feb 14.
6
The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis.罗曼诺夫研究发现，在接受维持性血液透析且未接触过病毒的患者中，对新冠病毒mRNA疫苗的体液免疫和细胞免疫反应受损。
Kidney Int. 2021 Oct;100(4):928-936. doi: 10.1016/j.kint.2021.07.005. Epub 2021 Jul 18.
7
Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls.血液透析患者在接种 COVID-19 mRNA 疫苗后的抗体反应明显低于健康对照者。
Nephrol Dial Transplant. 2021 Aug 27;36(9):1709-1716. doi: 10.1093/ndt/gfab179.
8
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.通过野生型噬斑减少中和试验、微量中和试验和假型病毒中和试验来定量 SARS-CoV-2 中和抗体。
Nat Protoc. 2021 Jun;16(6):3114-3140. doi: 10.1038/s41596-021-00536-y. Epub 2021 Apr 23.